Time-space trends in cancer incidence in the Netherlands in 1989-2003

International Journal of Cancer

Volumn 122, Issue 9, 2008, Pages 2106-2114

  Siesling, Sabine ^a   Van Der Aa, Maaike A ^a   Coebergh, Jan W W ^b,c   Pukkala, Eero ^d  

^a Integraal Kankercentrum Stedendriehoek Twente   (Netherlands)

^b The Netherlands   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d FINNISH CANCER REGISTRY   (Finland)

Author keywords

Cancer incidence; Early detection; Map animations; Risk determinants; Time space trends

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CITY; COLORECTAL CANCER; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; NEOPLASM; NETHERLANDS; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; RURAL AREA; SEASHORE; SEX RATIO; STANDARDIZATION; STOMACH CANCER; TIME; TREND STUDY; UTERINE CERVIX CANCER; ADOLESCENT; CHILD; GASTROINTESTINAL TUMOR; INCIDENCE; LUNG TUMOR; MASS SCREENING; MIDDLE AGED; PRESCHOOL CHILD; REGISTER; RETROSPECTIVE STUDY; RISK FACTOR; SKIN TUMOR; UROGENITAL TRACT TUMOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; EARLY DIAGNOSIS; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MASS SCREENING; MELANOMA; MIDDLE AGED; NEOPLASMS; NETHERLANDS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SKIN NEOPLASMS; UROGENITAL NEOPLASMS;

EID: 40749121350     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23358     Document Type: Article

References (58)

1. Olsen JH, Andersen A, Pukkala E, Tryggvadottir L, Gerhardsson de Verdier M, Winther JF. Avoidable cancers in the Nordic countries. 1997;105.
2. Soerjomataram I, de VE, Pukkala E, Coebergh JW. Excess of cancers in Europe: a study of eleven major cancers amenable to lifestyle change. Int J Cancer 2007;120:1336-43.
3. Siesling S, van Dijck JA, Visser O, Coebergh JW. Trends in incidence of and mortality from cancer in The Netherlands in the period 1989-1998. Eur J Cancer 2003;39:2521-30.
4. Schouten LJ, Hoppener P, van den Brandt PA, Knottnerus JA, Jager JJ. Completeness of cancer registration in Limburg, The Netherlands. Int J Epidemiol 1993;22:369-76.
5. Pukkala E, Söderman B, Okeanov A, Storm H, Rahu M, Hakulinen T, Becker N, Stabenow R, Bjarnadottir K, Stengrevics A, Gurevicius R, Glattre E, et al. Cancer atlas of Northern Europe. Helsinki: 2001.
6. Howe HL, Keller JE, Lehnherr M. Relation between population density and cancer incidence, Illinois, 1986-1990. Am J Epidemiol 1993;138:29-36.
7. CBS. http://statline.cbs.nl/StatWeb. 2005.
8. Stirbu I, Kunst AE, Vlems FA, Visser O, Bos V, Deville W, Nijhuis HG, Coebergh JW. Cancer mortality rates among first and second generation migrants in the Netherlands: convergence toward the rates of the native Dutch population. Int J Cancer 2006;119:2665-72.
9. Hakulinen T, Pukkala E. Future incidence of lung cancer: forecasts based on hypothetical changes in the smoking habits of males. Int J Epidemiol 1981;10:233-40.
10. La Vecchia C, Boyle P, Franceschi S, Levi F, Maisonneuve P, Negri E, Lucchini F, Smans M. Smoking and cancer with emphasis on Europe. Eur J Cancer 1991;27:94-104.
11. Janssen-Heijnen ML, Coebergh JW. The changing epidemiology of lung cancer in Europe. Lung Cancer 2003;41:245-58.
12. Stichting Volksgezondheid en Roken, Roken dhf. http://www.stivoro.nl. 2007 B.C.
13. Pukkala E, Guo J, Kyyronen P, Lindbohm ML, Sallmen M, Kauppinen T. National job-exposure matrix in analyses of census-based estimates of occupational cancer risk. Scand J Work Environ Health 2005;31:97-107.
14. Sankila RJ, Karjalainen ES, Oksanen HM, Hakulinen TR, Teppo LH. Relationship between occupation and lung cancer as analyzed by age and histologic type. Cancer 1990;65:1651-6.
15. Botterweck AA, Schouten LJ, Volovics A, Dorant E, van den Brandt PA. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 2000;29:645-54.
16. Weiderpass E, Pukkala E. Time trends in socioeconomic differences in incidence rates of cancers of gastro-intestinal tract in Finland. BMC Gastroenterol 2006;6:41.
17. Corley DA, Buffler PA. Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the cancer incidence in five continents database. Int J Epidemiol 2001;30:1415-25.
18. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-31.
19. Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 1999;130:883-90.
20. Brown LM, Swanson CA, Gridley G, Swanson GM, Schoenberg JB, Greenberg RS, Silverman DT, Pottern LM, Hayes RB, Schwartz AG. Adenocarcinoma of the esophagus: role of obesity and diet. J Natl Cancer Inst 1995;87:104-9.
21. Thun MJ, Peto R, Lopez AD, Monaco JH, Henley SJ, Heath CW, Jr, Doll R. Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med 1997;337:1705-14.
22. van Loon AJ, Goldbohm RA, van den Brandt PA. Socioeconomic status and stomach cancer incidence in men: results from The Netherlands Cohort Study. J Epidemiol Community Health 1998;52:166-71.
23. Ghadirian P, Maisonneuve P, Perret C, Lacroix A, Boyle P. Epidemiology of sociodemographic characteristics, lifestyle, medical history, and colon cancer: a case-control study among French Canadians in Montreal. Cancer Detect Prev 1998;22:396-404.
24. Negri E, Braga C, La VC, Franceschi S, Filiberti R, Montella M, Falcini F, Conti E, Talamini R. Family history of cancer and risk of colorectal cancer in Italy. Br J Cancer 1998;77:174-9.
25. Pischon T, Lahmann PH, Boeing H, Friedenreich C, Norat T, Tjonneland A, Halkjaer J, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Guernec G, Bergmann MM, et al. Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2006;98:920-31.
26. International Agency for Research on Cancer, Globocan. http://www-dep.iarc.fr/. 2007.
27. RIVM, Nationaal Kompas Volksgezondheid. http://www.nationaalkompas.nl. 2007.
28. Rimpela AH, Pukkala EI. Cancers of affluence: positive social class gradient and rising incidence trend in some cancer forms. Soc Sci Med 1987;24:601-6.
29. Rossing MA, Tang MT, Flagg EW, Weiss LK, Wicklund KG, Weiss NS. Body size and risk of epithelial ovarian cancer (United States). Cancer Causes Control 2006;17:713-20.
30. Klip H, Burger CW, Kenemans P, van Leeuwen FE. Cancer risk associated with subfertility and ovulation induction: a review. Cancer Causes Control 2000;11:319-44.
31. Beral V, Bull D, Green J, Reeves G. Ovarian cancer and hormone replacement therapy in the Million Women Study. Lancet 2007;369:1703-10.
32. van Leeuwen FE, Rookus MA. The role of exogenous hormones in the epidemiology of breast, ovarian and endometrial cancer. Eur J Cancer Clin Oncol 1989;25:1961-72.
33. Hinkula M, Pukkala E, Kyyronen P, Kauppila A. Incidence of ovarian cancer of grand multiparous women - a population-based study in Finland. Gynecol Oncol 2006;103:207-11.
34. Soerjomataram I, Louwman WJ, de VE, Lemmens VE, Klokman WJ, Coebergh JW. Primary malignancy after primary female breast cancer in the South of the Netherlands, 1972-2001. Breast Cancer Res Treat 2005;93:91-5.
35. Kazerouni N, Greene MH, Lacey JV, Jr, Mink PJ, Schairer C. Family history of breast cancer as a risk factor for ovarian cancer in a prospective study. Cancer 2006;107:1075-83.
36. Moller H, Skakkebaek NE. Testicular cancer and cryptorchidism in relation to prenatal factors: case-control studies in Denmark. Cancer Causes Control 1997;8:904-12.
37. Richiardi L, Akre O, Lambe M, Granath F, Montgomery SM, Ekbom A. Birth order, sibship size, and risk for germ-cell testicular cancer. Epidemiology 2004;15:323-9.
38. Weir HK, Marrett LD, Kreiger N, Darlington GA, Sugar L. Pre-natal and peri-natal exposures and risk of testicular germ-cell cancer. Int J Cancer 2000;87:438-43.
39. Moller H. Work in agriculture, childhood residence, nitrate exposure, and testicular cancer risk: a case-control study in Denmark. Cancer Epidemiol Biomarkers Prev 1997;6:141-4.
40. Toledano MB, Jarup L, Best N, Wakefield J, Elliott P. Spatial variation and temporal trends of testicular cancer in Great Britain. Br J Cancer 2001;84:1482-7.
41. Autier P, Dore JF, Lejeune F, Koelmel KF, Geffeler O, Hille P, Cesarini JP, Lienard D, Liabeuf A, Joarlette M. Recreational exposure to sunlight and lack of information as risk factors for cutaneous malignant melanoma. Results of an European Organization for Research and Treatment of Cancer (EORTC) case-control study in Belgium, France and Germany. The EORTC Malignant Melanoma Cooperative Group. Melanoma Res 1994;4:79-85.
42. de Vries E, Schouten LJ, Visser O, Eggermont AM, Coebergh JW. Rising trends in the incidence of and mortality from cutaneous melanoma in the Netherlands: a Northwest to Southeast gradient? Eur J Cancer 2003;39:1439-46.
43. KNMI. Zonneschijnduur (in uren) 1961-1990 [in Dutch]. De Bilt; 2001.
44. Krol AD, van der Rhee HJ, Dieleman M, Welvaart K. [The 'freckle bus' campaign; an unhealthy phenomenon or a sensible experiment?]. Ned Tijdschr Geneeskd 1990;134:2047-50.
45. Bataille V, Boniol M, de Vries E, Severi G, Brandberg Y, Sasieni P, Cuzick J, Eggermont A, Ringborg U, Grivegnee AR, Coebergh JW, Chignol MC, et al. A multicentre epidemiological study on sunbed use and cutaneous melanoma in Europe. Eur J Cancer 2005;41:2141-9.
46. Autier P, Dore JF, Lejeune F, Koelmel KF, Geffeler O, Hille P, Cesarini JP, Lienard D, Liabeuf A, Joarlette M. Cutaneous malignant melanoma and exposure to sunlamps or sunbeds: an EORTC multicenter case-control study in Belgium, France and Germany. EORTC Melanoma Cooperative Group. Int J Cancer 1994;58:809-13.
47. Pukkala E. Cancer risk by social class and occupation. A survey of 109,000 cancer cases among Finns of working age. Contributions to Epidemiology and Biostatistics. Basel: Karger, 1995.
48. Visser O, van der Kooy K, van Peppen AM, Ory FG, van Leeuwen FE. Breast cancer risk among first-generation migrants in the Netherlands. Br J Cancer 2004;90:2135-7.
49. Pukkala E, Weiderpass E. Time trends in socio-economic differences in incidence rates of cancers of the breast and female genital organs (Finland, 1971-1995). Int J Cancer 1999;81:56-61.
50. Hakama M, Hakulinen T, Pukkala E, Saxen E, Teppo L. Risk indicators of breast and cervical cancer on ecologic and individual levels. Am J Epidemiol 1982;116:990-1000.
51. Hakama M, Louhivuori K. A screening programme for cervical cancer that worked. Cancer Surv 1988;7:403-16.
52. Boon ME, van Ravenswaay Claasen HH, van Westering RP, Kok LP. Urbanization and the incidence of abnormalities of squamous and glandular epithelium of the cervix. Cancer 2003;99:4-8.
53. Visser O, van Leeuwen FE. Cancer risk in first generation migrants in North-Holland/Flevoland, The Netherlands, 1995-2004. Eur J Cancer 2007.
54. Haks K, Schout C, Cremer WS, Sigurdsson V, van Ameijden EJ. [Increased consultations and numbers of sexually transmitted diseases at the STD clinic of Utrecht, 1994-2002]. Ned Tijdschr Geneeskd 2004;148:1632-5.
55. Roobol MJ, Kirkels WJ, Schroder FH. Features and preliminary results of the Dutch centre of the ERSPC (Rotterdam, the Netherlands). BJU Int 2003;92 (Suppl 2):48-54.
56. Post PN, Kil PJ, Crommelin MA, Schapers RF, Coebergh JW. Trends in incidence and mortality rates for prostate cancer before and after prostate-specific antigen introduction. A registry-based study in southeastern Netherlands, 1971-1995. Eur J Cancer 1998;34:705-9.
57. Pukkala E, Weiderpass E. Socio-economic differences in incidence rates of cancers of the male genital organs in Finland, 1971-95. Int J Cancer 2002;102:643-8.
58. Stattin P, Johansson R, Lodnert R, Andren O, Bill-Axelsson A, Bratt O, Damber JE, Hellstrom M, Hugosson J, Lundgren R, Tornblom M, Varenhorst E, et al. Geographical variation in incidence of prostate cancer in Sweden. Scand J Urol Nephrol 2005;39:372-9.